Comment on Vadney and Kraushaar's "Effect of switching from Depakene to generic valproic acid on individuals with mental retardation".
Alvarez
N
N
Wrentham Developmental Center, MA 02093, USA.
Williams
R
R
D000927:Anticonvulsants / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D014635:Valproic Acid / Q000627:therapeutic use*
D000927:Anticonvulsants; D014635:Valproic Acid